Albiqur Tablets

Adult dose

Generally, 2 tablets are taken orally twice daily, regardless of meals, in the morning and before bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or administer 4 tablets once daily before bedtime. Particularly for patients with duodenal ulcers, administering 4 tablets twice daily in the morning and before bedtime can yield a higher treatment rate. For prevention of ulcers caused by NSAID use or in combination therapy to prevent gastric or duodenal ulcers with long-term NSAID use, the dosage is the same. Generally, diseases induced by NSAIDs are usually healed within 8 weeks, although healing times may occasionally be extended for some patients. For recurrent ulcer patients who had excellent results with short-term treatment of this medication, a maintenance therapy of 2 tablets once daily before bedtime is administered. 2) Gastroesophageal reflux disease Administer 2 tablets twice daily for 8 weeks, or administer 4 tablets once daily before bedtime. In the case of severe gastroesophageal reflux disease, the dosage may be increased to 4 tablets four times a day. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets three times daily, with the possibility of increasing the dose as needed. For severe cases, as directed by a physician, up to 6 g of ranitidine may be administered daily. 4) Peptic ulcer, acute stress ulcer, and upper gastrointestinal bleeding due to acute mucosal lesions When oral administration becomes possible, switch to oral administration from injection and administer 2 tablets twice daily. 5) Pre-anesthesia administration (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before anesthesia induction. It is preferable to also administer 2 tablets the night before surgery.

This medication should not be used in patients undergoing dialysis or those who have had an allergic reaction to this medication or its ingredients. It should also not be administered to patients with a rare condition called acute porphyria, and caution is necessary for patients with poor kidney function or those who have undergone gastrointestinal surgery. Women who are pregnant or may become pregnant, premature infants, newborns, and patients who need to restrict potassium intake should also avoid using this medication. Patients with hepatic dysfunction or a history of drug allergies, elderly patients, and patients with a history of kidney disease should use this medication with caution. Particular care should be taken when taking it with NSAIDs, and it may mask the symptoms of gastric cancer; therefore, gastric ulcer patients or middle-aged and older patients with new onset dyspeptic symptoms should have their malignancy ruled out before treatment. Patients with Helicobacter pylori infection in gastric or duodenal ulcers must receive eradication therapy, and critical patients in intensive care or patients with hypophosphatemia and difficulty swallowing should be cautious as well. This medication can cause serious allergic reactions, such as anaphylactic shock, so if any abnormal symptoms occur while taking it, administration should be immediately stopped and medical attention sought. Symptoms of allergy such as skin rash, hives, angioedema, fever, bronchospasm, and hypotension have also been reported, and if these symptoms occur, the medication should be discontinued. Decreased blood cell counts, liver function abnormalities, cardiac arrhythmia, gastrointestinal symptoms (nausea, vomiting, constipation, diarrhea, etc.), and neurological symptoms (dizziness, drowsiness, confusion, seizures, etc.) can also occur rarely, so attention is needed. Especially patients with impaired kidney function may experience neurological symptoms more easily, so monitoring is necessary. Muscle pain or joint pain, skin rashes, and hair loss have also been reported as side effects; if there are abnormal symptoms, immediate consultation with medical staff is required. This medication is best not used long-term, and it is recommended to switch to another medication if there is no therapeutic effect. Elderly patients or those with chronic lung disease, diabetes, or weakened immunity may be at higher risk of pneumonia, so caution should be exercised. If dizziness or drowsiness is experienced during use, avoid driving or operating hazardous machinery. This medication can interact with other drugs, so particularly when taken with anticoagulants, antibiotics, and anticonvulsants, consulting with a physician or pharmacist is essential. It is safest for women who are pregnant or breastfeeding not to use this medication, and safety in pediatric patients has not been established, so its use is not recommended. Caution is needed as false positive results may occur in urine protein tests during examinations. In case of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, and in some cases, blood dialysis may be required. Finally, this medication can reduce gastric acid secretion, which can promote bacterial growth in the stomach, so ophthalmic examinations may also be needed during long-term use.

Serious side effects

Hives, severe swelling (angioedema), chest tightness (chest pain), difficulty breathing (bronchospasm), cold sweats, paleness, anaphylactic shock, severe allergic reactions, severe rashes with high fever, blisters, peeling skin, pain in the oral/ocular mucosa, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanying cough and fever, respiratory problems, yellowing of the skin or eyes (jaundice), general

Mild side effects

• Skin rash
• hives
• angioedema
• fever
• bronchospasm
• hypotension
• chest pain
• granulocytopenia
• leukopenia
• thrombocytopenia

This medication should be stored in a sealed container that does not allow air to enter, at a temperature between 1 and 30 degrees Celsius. Storing it in this way can maintain its efficacy and prevent deterioration.

Appearance

Green round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle